sub:assertion {
  d:DB00515 dv:ddi-interactor-in dr:DB00515_DB01248 .
  d:DB01248 dv:ddi-interactor-in dr:DB00515_DB01248 .
  dr:DB00515_DB01248 dct:identifier "drugbank_resource:DB00515_DB01248" ;
    dct:title "DDI between Cisplatin and Docetaxel - Platinum derivatives such as cisplatin may enhance the myelosuppressive effect of taxane derivatives such as docetaxel. Administer taxane derivative before platinum derivative when given as sequential infusions to limit toxicity. Administer paclitaxel before cisplatin, when given as sequential infusions, to limit toxicity. Problems associated with other taxane/platinum combinations are possible, although unsubstantiated. Administering the taxane derivative before the platinum derivative seems prudent."@en ;
    a dv:Drug-Drug-Interaction ;
    rdfs:label "DDI between Cisplatin and Docetaxel - Platinum derivatives such as cisplatin may enhance the myelosuppressive effect of taxane derivatives such as docetaxel. Administer taxane derivative before platinum derivative when given as sequential infusions to limit toxicity. Administer paclitaxel before cisplatin, when given as sequential infusions, to limit toxicity. Problems associated with other taxane/platinum combinations are possible, although unsubstantiated. Administering the taxane derivative before the platinum derivative seems prudent.  [drugbank_resource:DB00515_DB01248]"@en .
}